Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
32
Number of overlapping holdings
16.9%
% of CXSE's 191 holdings also in KURE
40.5%
% of KURE's 74 holdings also in CXSE
Overlap by Weight
Sector Drift (CXSE minus KURE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CXSE |
Weight in KURE |
Overlap | |
|---|---|---|---|---|
 |
BEIGENE, LTD. | 1.3% | 4.1% | 1.3% |
|
JIANGSU HENGRUI MEDICINE CO., LTD. CLASS A | 1.0% | 5.7% | 1.0% |
 |
WUXI BIOLOGICS (CAYMAN) INC. | 1.0% | 3.8% | 1.0% |
|
INNOVENT BIOLOGICS, INC. | 0.9% | 3.2% | 0.9% |
|
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. CLASS A | 0.9% | 7.4% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
CXSE Overweight Relative to KURE
|
ALIBABA GROUP HOLDING LTD. | 10.3% |
 |
PINDUODUO, INC. SPONSORED ADR CLASS | 5.7% |
|
NETEASE, INC | 5.0% |
|
PING AN INSURANCE GROUP CO-H | 3.9% |
|
MEITUAN DIANPING | 3.7% |
|
CONTEMPORARY AMPEREX TECHNOLOGY CO., | 2.4% |
|
PING AN INSURANCE (GROUP) COMPANY OF | 2.3% |
|
JD.COM, INC. CLASS A | 2.0% |
|
LI AUTO, INC. CLASS A | 1.9% |
|
KUAISHOU TECHNOLOGY CLASS B | 1.9% |
CXSE Underweight Relative to KURE
|
SHENZHEN MINDRAY BIO-MEDICAL ELECTRO | -6.5% |
|
JIANGSU HENGRUI MEDICINE CO., LTD. C | -4.7% |
|
CHINA PHARMACEUTICAL GROUP | -3.6% |
|
ZHANGZHOU PIENTZEHUANG PHARMACEUTICA | -2.9% |
|
WUXI BIOLOGICS (CAYMAN) INC. | -2.9% |
|
BEIGENE, LTD. | -2.8% |
|
AIER EYE HOSPITAL GROUP CO., LTD. CL | -2.5% |
|
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS | -2.4% |
|
INNOVENT BIOLOGICS, INC. | -2.3% |
|
WUXI APPTEC CO., LTD. CLASS A | -2.3% |